Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDR91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RSPH4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507258 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CNPY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM222A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCMH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930370 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLEK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on